Practice points• Chronic pancreatitis (CP) is a progressive disease characterized by an irreversible damage inflicted to the pancreas.It is associated with varying degrees of inflammation, fibrosis, increased risk of neoplasms and alterations to the exocrine component of the pancreas, with the varying involvement of islets of Langerhans.• With time, available therapy becomes ineffective and can no longer relieve the progressive chronic pain associated with CP.• The goal of near-total pancreatectomy or total pancreatectomy (TP) for CP, and other pancreatic disorders, is to alleviate the intractable pain inflicted by CP in patients who fail other forms of treatment approaches.• Near-total pancreatectomy and TP alone result in insulin and glucagon deficiency, as well as surgically induced insulin-dependent pancreatogenic diabetes with poor metabolic control.• Patients with pancreatogenic diabetes may have wide daily glycemic excursions and hypoglycemia due to endocrine failure and exocrine deficiency. Glucagon and insulin deficiency, and poor metabolic control are often difficult to manage.• Islet autotransplantation (IAT) following pancreatic resection is performed as the prophylaxis for iatrogenic diabetes which often develops following pancreatic resection, near-total pancreatectomy or TP.• IAT is demonstrated to improve pain, alleviate the risk of 'brittle diabetes' and offers freedom from exogenous insulin in a large number of patients. Approximately 40% of these patients are able to achieve insulin independence. In addition, diabetes control in recipients of IAT is superior to those patients who are not transplanted.• IAT represents a reasonable therapeutic option for the treatment of glycemic disorders in a wide range of the population, which includes children as well as elderly patients.For reprint orders, please contact: reprints@futuremedicine.com